Real-World Data / Real-Word Evidence Resources
-
Reduce Avoidable Protocol Amendments By Anticipating Operational Pitfalls
5/13/2026
This report examines how amendment drivers vary across therapeutic areas and how those changes impact execution, patient burden, site workload, timelines, and study costs.
-
2024 MedTech Regulatory Updates: 4 Areas Of Interest
4/15/2024
In 2024, McKinsey's projections foresee a promising year for the MedTech industry, driven by innovation but shadowed by regulatory uncertainty.
-
Readying Your Clinical Trial For Linkage With Real-World Data
9/20/2022
Discover why the near ubiquity of real-world data (RWD) sources has prompted sponsors to consider RWD’s role in study programs and regulatory bodies to issue guidance on their use in clinical development.
-
Frequently Asked Questions About IRMS MAX
3/14/2025
Improve your information access and capabilities with the definitive gold standard of medical information systems.
-
Optimize Your Oncology Trial Protocol With Real-World Data
9/16/2024
Set your next oncological clinical trials up for success using high-quality real-world data (RWD) to anticipate and confront potential problems early on.
-
The Value Of Tokenizing Clinical Development Data
4/6/2023
Most use cases of real-world data don’t require tokenization to deliver value. However, given industry challenges and the influx of information, see how ROI can be achieved from trial data tokenization.
-
How To Use Real World Data To Maximize Patient Recruitment In DCTs
2/7/2022
In the clinical trial space, RWD helps support research design, protocol and patient engagement goals. Perhaps the most immediate way clinical research leaders can harness the power of RWD is as a tool for optimized patient recruitment. Learn how this can be done in the available blog.
-
The Future Of Health Data: A 2022 Life Sciences Industry Insights Report
11/14/2022
A survey of life sciences leaders reveals some of the key challenges that come with using real-world data (RWD) for innovation, along with their vision and predictions for how RWD can accelerate drug development and improve patient outcomes.
-
Single-Arm Trials Use Real-World Evidence For Rare Disease Drug Development
3/1/2022
In rare disease product development, where a placebo control group may not be an option, a single-arm trial can be a successful approach. Gain insight into the regulatory considerations for single-arm trials.
-
Overcoming Real-World Data Capture Challenges In Phase 4 Trials
1/29/2024
As the demand for real-world insights continues to grow, learn why navigating challenges and leveraging emerging opportunities becomes crucial for advancing clinical research in the real-world setting.